Double Pump tapped for LipiGesic-M marketing efforts
SCHOFIELD, Wis. — In preparation for a retail launch, PuraMed BioScience on Monday announced it has entered into an agreement with Double Pump to enhance marketing efforts and product awareness surrounding the company’s homeopathic analgesic LipiGesic-M.
"We have retained Double Pump to assist us in our marketing campaign for LipiGesic-M, which will include a search for a high-profile spokesperson for the product, as well as introduction to various sales channels," stated PuraMed CEO Russell Mitchell. "We believe Double Pump’s experience with international brands, as well as their relationships with highly recognizable celebrities and athletes, makes them an excellent choice as a partner in launching LipiGesic-M on the national level and building awareness of the product to the level of becoming a household name."
PuraMed also stated it recently submitted a clinical study supporting the efficacy of LipiGesic M to an unnamed medical journal for peer review.
Distribution for INGfertility’s Pre~Seed expands
SPOKANE, Wash. — INGfertility on Monday announced that its Pre~Seed "fertility-friendly" personal lubricant has added distribution through Walgreens, including Duane Reade.
Pre~Seed’s formula matches the pH, osmolality (ion content) and viscosity (thickness) of a woman’s fertile fluids. It is applied internally prior to intercourse to support an optimal environment for sperm. In contrast, medical studies have shown the damage to sperm that can be caused by most common lubricants. "Many couples who are trying to conceive have increased incidence of vaginal dryness, due to the stress of ‘having to have’ intercourse during the woman’s fertile time," stated GD Clifton, INGfertility CEO. "Pre~Seed offers a safe alternative for these couples.”
Pre~Seed also is available at CVS/pharmacy, the company reported.
Alli set to launch chewable tablet this year in Europe
LONDON — GlaxoSmithKline has received a license extension in Europe for its popular weight-loss pill Alli.
The drug maker said it plans to sell new chewable tablets this spring, available at pharmacies throughout the United Kingdom.
Alli has been available in the United Kingdom since early 2009.